Patent on neuro-degenerative drug to Suven Life Sciences

Drug firm Suven Life Sciences has been granted a patent each by Eurasia, Europe, Israel and Macau for a drug used in the treatment of neuro-degenerative diseases. As of now, with the new patents, Suven has a total of 15 granted patents from Eurasia, 18 from Europe, 8 from Israel and 5 from Macau [more].